Gene · 50848
Papers3,726
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,726
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Triple negative breast cancer metastasis is hindered by a peptide antagonist of F11R/JAM‑A protein. | Cancer Cell Int | 2023 | 37563645 | PubTator, text mining | PubMed |
| Candidate biomarkers and persistent transcriptional responses after low and high dose ionizing radiation at high dose rate. | Int J Radiat Biol | 2023 | 37549410 | PubTator, text mining | PubMed |
| Tight junction disruption and the pathogenesis of the chronic complications of diabetes mellitus: A narrative review. | World J Diabetes | 2023 | 37547580 | PubTator, text mining | PubMed |
| Non-coding RNAs and gastrointestinal cancers prognosis: an umbrella review of systematic reviews and meta-analyses of observational studies. | Front Oncol | 2023 | 37546412 | PubTator, text mining | PubMed |
| Differential effects of SARS-CoV-2 variants on central nervous system cells and blood-brain barrier functions. | J Neuroinflammation | 2023 | 37537664 | PubTator, text mining | PubMed |
| Mechanisms of airway epithelial injury and abnormal repair in asthma and COPD. | Front Immunol | 2023 | 37520564 | PubTator, text mining | PubMed |
| Modulation of Reoviral Cytolysis (II): Cellular Stemness. | Viruses | 2023 | 37515162 | PubTator, text mining | PubMed |
| Modulation of Reoviral Cytolysis (I): Combination Therapeutics. | Viruses | 2023 | 37515160 | PubTator, text mining | PubMed |
| Host Cell Response to Rotavirus Infection with Emphasis on Virus-Glycan Interactions, Cholesterol Metabolism, and Innate Immunity. | Viruses | 2023 | 37515094 | PubTator, text mining | PubMed |
| Exploring Alternatives to Polyacrylamide: A Comparative Study of Novel Polymers in the Flocculation and Dewatering of Iron Ore Tailings. | Polymers (Basel) | 2023 | 37514409 | PubTator, text mining | PubMed |
| Polymeric Nanoparticles' Accumulation in Atopic Dermatitis: Clinical Comparison between Healthy, Non-Lesional, and Lesional Skin. | Pharmaceutics | 2023 | 37514111 | PubTator, text mining | PubMed |
| Nanoparticle Strategies to Improve the Delivery of Anticancer Drugs across the Blood-Brain Barrier to Treat Brain Tumors. | Pharmaceutics | 2023 | 37513992 | PubTator, text mining | PubMed |
| Platelet Glycoprotein-Ib (GPIb) May Serve as a Bridge between Type 2 Diabetes Mellitus (T2DM) and Atherosclerosis, Making It a Potential Target for Antiplatelet Agents in T2DM Patients. | Life (Basel) | 2023 | 37511848 | PubTator, text mining | PubMed |
| Unravelling the Role of P300 and TMPRSS2 in Prostate Cancer: A Literature Review. | Int J Mol Sci | 2023 | 37511059 | PubTator, text mining | PubMed |
| Clinical and Genetic Aspects of Alopecia Areata: A Cutting Edge Review. | Genes (Basel) | 2023 | 37510267 | PubTator, text mining | PubMed |
| Mesenchymal Stromal Cell-Derived Extracellular Vesicles for Vasculopathies and Angiogenesis: Therapeutic Applications and Optimization. | Biomolecules | 2023 | 37509145 | PubTator, text mining | PubMed |
| Liquid Biopsy in Neurological Diseases. | Cells | 2023 | 37508574 | PubTator, text mining | PubMed |
| The Interplay between Atherosclerosis and Cancer: Breast Cancer Cells Increase the Expression of Endothelial Cell Adhesion Markers. | Biology (Basel) | 2023 | 37508329 | PubTator, text mining | PubMed |
| Phloretin suppresses intestinal inflammation and maintained epithelial tight junction integrity by modulating cytokines secretion in in vitro model of gut inflammation. | Cell Immunol | 2023 | 37506521 | PubTator, text mining | PubMed |
| Monocyte-endothelial cell interactions in vascular and tissue remodeling. | Front Immunol | 2023 | 37483594 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/50848/papers?page=19